Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

A simple hospital checklist could flag hidden malnutrition in kids with IBD

NCT ID NCT06723418

Knowledge-focused Sponsor: University of Glasgow Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This study tests whether a standard nutrition screening tool, called PYMS, can accurately identify children with Crohn's disease or ulcerative colitis who are at risk of malnutrition. Researchers will use the tool on 2,000 children aged 4–18 with IBD in outpatient and inpatient clinics across different countries. If the tool doesn't work well, the team will develop a new, IBD-specific nutrition risk score called PIBD-NUTS. The goal is to help healthcare professionals spot nutritional needs earlier and improve care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Paediatric Yorkhill Malnutrition Score (PYMS) – a nutritional screening tool
What this could lead to
If the existing tool works well, it could be adopted widely to quickly identify children with IBD who need nutritional support. If not, it may lead to a new, IBD-specific nutrition risk score.
What could go wrong
This is an observational validation study, not a treatment trial, so it won't directly change outcomes. The existing tool may not be accurate enough in this population, and results may vary across different settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 2,000 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All IBD (Crohns disease \& ulcerative colitis) patients (4-18 years) either admitted to hospital, or visiting their gastroenterologist's outpatient clinic for routine visits are eligible.

Ages

4 to 18 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pediatric patients with either Crohn's disease or ulcerative colitis between the ages of (4-18 years) Exclusion Criteria: * Pediatric patients with IBDU

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Crohns disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Crohn disease inflammatory bowel disease ulcerative colitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Crohns disease Inflammatory bowel diseases (IBD) Ulcerative colitis (UC)

Contacts and locations

Locations

  • Children's Hospital Zagreb

    Zagreb, Croatia

  • Erasmus MC university medical centre

    Rotterdam, Netherlands

  • Great Ormond Street Hospital

    London, United Kingdom

  • Royal Hospital for Children and Young People

    Edinburgh, United Kingdom

  • Salzburg University Hospital

    Salzburg, Austria

  • The Children's Memorial Health Institute

    Warsaw, Poland

  • University Hospital Bristol and Weston

    Bristol, United Kingdom

  • University of Giessen

    Giessen, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.